Cyient DLM Reports 130% YOY Growth in Order Intake for H1, Records ₹195.75 Million Gain from Fair Valuation

1 min read     Updated on 14 Oct 2025, 06:14 PM
scanx
Reviewed by
Jubin VergheseScanX News Team
Overview

Cyient DLM has reported significant financial developments in its latest quarterly results. The company recorded a ₹195.75 million gain from fair valuation of earnout liability, boosting its other income. Reported PAT increased by 330.6% QoQ and 108% YoY to ₹32.20 crore. Revenue stood at ₹3,106.00 crore, up 11.60% QoQ but down 20.20% YoY. EBITDA margin improved to 10.00%, up 100 bps QoQ and 190 bps YoY. The company's H1 order intake exceeded ₹1,000 crore, showing a 130% YoY growth. Cyient DLM added two strategic customers in the electric mobility ecosystem and is focusing on diversifying its portfolio with Box-Build solutions.

21991489

*this image is generated using AI for illustrative purposes only.

Cyient DLM , a leading integrated partner for design-led manufacturing, has reported significant financial developments in its latest results. The company recorded a gain of ₹195.75 million as other income from the fair valuation of earnout liability, positively impacting its financial performance for the quarter. Additionally, Cyient DLM reported a remarkable 130% year-over-year growth in order intake for the first half of the year.

Financial Highlights

The company's quarterly results showcase several key financial metrics:

Metric Amount QoQ Change YoY Change
Revenue ₹3,106.00 crore 11.60% -20.20%
EBITDA ₹31.20 crore 24.40% -1.40%
EBITDA Margin 10.00% 100 bps 190 bps
Normalized PAT ₹12.60 crore 68.00% -18.70%
Reported PAT ₹32.20 crore 330.60% 108.00%

The reported PAT saw a substantial increase due to the one-off other income gains, including the ₹195.75 million from the fair valuation of earnout liability.

Operational Performance

Cyient DLM demonstrated strong operational resilience:

  • Free Cash Flow stood at ₹27 crore, marking the fourth consecutive quarter of positive cash flow.
  • H1 Order Intake exceeded ₹1,000 crore, representing a 130% YoY growth.
  • The company added two strategic customers in the electric mobility ecosystem.

Management Commentary

Rajendra Velagapudi, MD & CEO of Cyient DLM, stated, "Our profitability has improved significantly this quarter, reflecting the disciplined execution and strategic choices we have made this year. We continue to strengthen our capabilities, expand our customer base, and build a robust pipeline."

Strategic Developments

  • Cyient DLM is diversifying its portfolio, with Box-Build solutions driving healthy contribution from global markets outside India.
  • The company secured major Build-to-Spec (B2S) projects during the quarter, expected to progress into the next phase of development in the near term.
  • Investments are being made to enhance B2S capabilities, integrating advanced design, testing, and certification competencies.

Future Outlook

With a strong order intake growth and a pipeline of large deals in advanced stages, Cyient DLM is positioned for future growth. The company continues to leverage its engineering expertise and manufacturing capabilities to support new-age technologies, particularly in the rapidly evolving electric mobility sector.

The fair valuation gain on earnout liability, while a one-time event, contributes to the company's improved financial position and demonstrates its ability to manage financial obligations effectively.

Investors and stakeholders will likely keep a close watch on how Cyient DLM leverages this financial boost and strong order intake growth to fuel its strategic initiatives and drive sustainable growth in the coming quarters.

Historical Stock Returns for Cyient DLM

1 Day5 Days1 Month6 Months1 Year5 Years
-4.11%+4.47%+1.15%+2.62%-33.84%+11.31%
Cyient DLM
View in Depthredirect
like19
dislike

Cyient DLM Appoints Dr. Ganesh Natarajan as Independent Director

1 min read     Updated on 14 Oct 2025, 05:06 PM
scanx
Reviewed by
Shriram ShekharScanX News Team
Overview

Cyient DLM Limited has appointed Dr. Ganesh Natarajan as an Independent Director for a three-year term, effective October 14, 2025, subject to shareholder approval. Dr. Natarajan, currently Chairman of several organizations including 5F World and Honeywell Automation India, brings extensive experience in business transformation, innovation, and strategic leadership. The appointment follows a recommendation from the company's Nomination and Remuneration Committee and is expected to enhance Cyient DLM's governance and strategic direction in the electronic manufacturing services sector.

21987378

*this image is generated using AI for illustrative purposes only.

Cyient DLM Limited , a prominent player in the electronic manufacturing services sector, has announced the appointment of Dr. Ganesh Natarajan as an Independent Director to its Board. The appointment, effective from October 14, 2025, is for a three-year term, subject to shareholder approval.

Board Approval and Nomination Process

The decision to appoint Dr. Natarajan was made during a board meeting held on October 14, 2025. This appointment follows a recommendation from the company's Nomination and Remuneration Committee, adhering to corporate governance best practices.

Dr. Ganesh Natarajan's Profile

Dr. Natarajan brings a wealth of experience to Cyient DLM's board. He currently serves as the Chairman of several organizations, including:

  • 5F World
  • GTT Data Solutions
  • EPPS
  • Honeywell Automation India
  • Lighthouse Communities

His illustrious career includes leading roles in the growth of APTECH and Zensar. Dr. Natarajan is also a published author and has held leadership positions in industry bodies, including chairing NASSCOM.

Implications for Cyient DLM

The addition of Dr. Natarajan to the board is expected to bring valuable insights in areas such as:

  • Business transformation
  • Innovation
  • Strategic leadership

His extensive experience across multiple boards positions him well to contribute to Cyient DLM's governance and strategic direction.

Regulatory Compliance

In line with regulatory requirements, Cyient DLM has confirmed that Dr. Natarajan:

  1. Is not related to any directors, key managerial personnel, or promoters of the company.
  2. Has not been debarred from holding a directorship by any regulatory authority.

This appointment aligns with Cyient DLM's commitment to maintaining a strong and diverse board composition, potentially enhancing its corporate governance structure and strategic capabilities in the electronic manufacturing services industry.

Historical Stock Returns for Cyient DLM

1 Day5 Days1 Month6 Months1 Year5 Years
-4.11%+4.47%+1.15%+2.62%-33.84%+11.31%
Cyient DLM
View in Depthredirect
like19
dislike
More News on Cyient DLM
Explore Other Articles
468.15
-20.05
(-4.11%)